Sanofi’s CEO Says Its mRNA Based Covid-19 Vaccine Will Not Be Available This Year

The vaccine candidate against Covid-19 that is being developed jointly by the French drug maker Sanofi and Translate Bio of the United States “will not be ready this year”, announced the French firm’s chief executive in an interview to Le Journal du Dimanche newspaper. The company executive said that it is likely that the company…

Shift Of Beauty Business Online During Pandemic Helps L’Oreal Sales Rebound

With shoppers of beauty products flocking to shop from online sources during the coronavirus pandemic, the biggest cosmetics group of the world L’Oreal reported better than expected growth in revenues for the fourth quarter of the last year. The closure of airport duty-free shops and high street stores during the Covid-19 pandemic and the shift…

More Labels To Identify Accounts Of World Leader And Government Accounts To Be Added By Twitter

New labels to clearly identify more state-affiliated accounts, including the personal accounts of world’s leaders’ would be started by the social media platform Twitter from next week, the company said. The aim of this move is to provide greater clarity and context to users when they engage in any geopolitical conversation on the micro blogging…

US Suppliers Of Huawei Attempt To Reverse Last Minute Bans By Trump Administration

Additional time is being sought by semiconductor companies to appeal against the last minute movers by the last-minute Trump administration of the United States to block sales to Chinese telecoms company Huawei. According to reports quoting sources, the companies are hopeful of a reversal of policy even though analysts see it unlikely that the new…

Global Chip Shortage Forces Renault And Stellantis Cut Some Production

A global shortage crucial semiconductors has forced car makers Renault and Stellantis to announce suspension of car production at a number of their factories, the two companies have announced. There has been a shortage of chips used in engine management and driver-assistance systems of cars which has severely hit production of car makers all across…

AstraZeneca Covid-19 Vaccine Shows Lower Efficacy Against South African Variant Of The Virus

Only limited protection against mild disease caused by the South African variant of the novel coronavirus was exhibited by the Cvoid-19 vaccine developed by AstraZeneca and the University of Oxford, said a spokesman for the British drug maker. This statement from the firm was issued following a report published in the Financial Times where it…